Daniel Offen

Medicine & Life Sciences

1. Mesenchymal Stem Cells 100%
2. Parkinson Disease 94%
3. Nerve Growth Factors 60%
4. Dopamine 57%
5. Neurodegenerative Diseases 48%
6. Amyotrophic Lateral Sclerosis 46%
7. Oxidative Stress 41%
8. Stem Cells 34%
9. Apoptosis 34%
10. Oxidopamine 33%
11. Antioxidants 31%
12. Autoimmune Experimental Encephalomyelitis 30%
13. Neurons 29%
14. Extracellular Vesicles 28%
15. Transgenic Mice 28%
16. Brain 27%
17. Exosomes 27%
18. Therapeutics 26%
19. Dopaminergic Neurons 26%
20. Cell- and Tissue-Based Therapy 23%
21. Mesenchymal Stem Cell Transplantation 23%
22. Multiple Sclerosis 22%
23. PC12 Cells 21%
24. Levodopa 21%
25. Quinolinic Acid 21%
26. Neurogenesis 20%
27. Astrocytes 20%
28. Substantia Nigra 20%
29. Alzheimer Disease 19%
30. Phencyclidine 19%
31. Myelin-Oligodendrocyte Glycoprotein 19%
32. Neuroprotection 18%
33. Transplantation 17%
34. Cell Death 17%
35. Blood-Brain Barrier 17%
36. Genes 16%
37. Wounds and Injuries 16%
38. Huntington Disease 15%
39. Pathology 15%
40. Schizophrenia 14%
41. Autism Spectrum Disorder 14%
42. Proteins 14%
43. Sciatic Nerve 14%
44. Brain-Derived Neurotrophic Factor 13%
45. Reactive Oxygen Species 13%
46. dopamine melanin 13%
47. Synucleins 13%
48. ND-13 DJ-1 based peptide 12%
49. In Vitro Techniques 12%
50. Animal Models 12%